Singapore Trials $3M in Life-Changing Health Tech

A stroke patient in Japan who couldn't open his hands for years can now grasp objects again after just two weeks of therapy. That breakthrough is now coming to Singapore, along with four other medical innovations that could transform how we treat everything from strokes to heart failure.

Five startups won a combined $3 million through Healthcare InnoMatch 2025 to test their technologies in Singapore's public hospitals. The program, presented by Temasek Foundation and supported by the Ministry of Health, pairs innovators with real medical teams to prove their solutions work in the real world.

Japanese startup Lifescapes is bringing its Brain-Computer Interface therapy to National University Hospital. The technology uses sensors to read brain signals when someone tries to move, then strengthens those signals and sends them to muscles through gentle electrical pulses. Over 900 patients in Japan have tested it, with many seeing dramatic improvements in a fraction of the usual recovery time.

Traditional rehabilitation programs can take 12 weeks or longer. This approach helps rewire the brain and nerves in just two weeks by tapping into neuroplasticity, the brain's natural ability to form new connections.

Swedish startup Acorai is bringing a completely different kind of breakthrough. Their handheld device measures cardiac pressure in five minutes without needles or invasive procedures. Right now, getting accurate readings means inserting a tube into the heart, a process that requires hospitalization and carries risks.

The innovation challenge has been running since 2021 and has already enabled 16 test projects using AI, digital health, and robotics. More than 2,800 patients have benefited from innovations in mental health, diabetes care, and other areas.

This year's winners are also developing tremor-steadying wearables, non-invasive heart failure monitoring, and AI that catches cancers earlier. Each technology aims to make care faster, safer, and more accessible to patients who need it most.

The Ripple Effect

Singapore's healthcare system is becoming a proving ground for medical breakthroughs that could help millions across Asia. The country's robust data systems, culture of innovation, and public trust make it ideal for testing new technologies quickly. When innovations prove themselves here, they can scale up fast and spread to neighboring countries facing similar health challenges.

National University Hospital CEO Professor Aymeric Lim emphasized the hospitals' commitment to making proven innovations available to everyone who needs them, not just those who can afford expensive treatments. That means stroke patients in public hospitals could soon access the same cutting-edge brain therapy that worked miracles in Japan.

For patients, these technologies represent more than medical advances. Being able to button a shirt or hold a cup of coffee again builds confidence and accelerates recovery, letting people spend less time in hospitals and return to normal life sooner.